Status:
COMPLETED
EmboCube Gelatin Embolization to Control Bleeding or Hemorrhaging
Lead Sponsor:
Merit Medical Systems, Inc.
Conditions:
Hemorrhage
Bleeding Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
This is a multicenter, observational study of the use of EmboCube Embolization Gelatin to control hemorrhaging and bleeding. The study is designed to enable the collection, analysis, and reporting of ...
Eligibility Criteria
Inclusion
- Age ≥18 years
- Subject requires embolization and is suitable for treatment with EmboCube in accordance with device Instructions For Use for the treatment of bleeding or hemorrhage.
- Subject provides written informed consent to study data collection.
Exclusion
- Bleeding site in the neck, head, or brain.
- Subject has co-morbidity with survival prognosis of less than 30 days, in the opinion of the treating physician
- In the investigator's opinion, participation in the study may not be in the subject's best interest.
Key Trial Info
Start Date :
November 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2024
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT05307783
Start Date
November 30 2022
End Date
April 10 2024
Last Update
January 22 2025
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Chris O'Brien Lifehouse
Camperdown, New South Wales, Australia, 2050
2
South Western Sydney Local Health District
Liverpool, Australia
3
Alfred Health
Sydney, Australia
4
Centre Hospitalier Universitaire de Nîmes - Caremeau
Nîmes, France